RYI

Viracta Therapeutics Inc Cross-source read
UnclassifiedCUSIP 92765F108

No active 13F manager changed its position in RYI last quarter. Over the last 180 days, 2 insiders sold and none bought, a net -$509K in open-market trades.

Tracked 13F holders
0
6 in Q1 2025 filings
13F value (tracked)
$0
Smart-money readMixed
Net sellingNet buying
Funds · active managers, latest 13F
0 adding · 0 trimming
Insiders · Form 4 open-market, 180d
0 buying · 2 selling · -$509K
US House · STOCK Act, 180d
0 buying · 0 selling

The legs disagree, or only one of them leans.

Who owns RYI?

0 tracked 13F filers · ranked by shares held

Not held in any tracked 13F filing yet.

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Insider activity (Form 4)

Full insider page →
Sells · 180d
$509K
2 insiders
Net · 180d
-$509K
5 open-market transactions
DateInsiderRoleActionSharesValue
Jul 28, 2026Kannan Molly DCAO & Corporate ControllerSell (S)500$16K
Jun 11, 2026Kannan Molly DCAO & Corporate ControllerSell (S)1K$30K
May 29, 2026Kannan Molly DCAO & Corporate ControllerSell (S)3K$85K
May 28, 2026Silver Mark S.EVP, Chief Legal/Risk OfficerSell (S)11K$312K
May 13, 2026Kannan Molly DCAO & Corporate ControllerSell (S)3K$65K
Feb 3, 2026Claussen James JExecutive Vice President & CFOSell (S)5K$149K
Jan 22, 2026Lehner Edward J.President & CEO, DirectorSell (S)59K$1.8M
Jan 21, 2026Lehner Edward J.President & CEO, DirectorSell (S)1K$30K
Aug 28, 2025Sundarrajan AlaguChief Information OfficerSell (S)15K$337K
Aug 20, 2025Kannan Molly DCAO & Corporate ControllerSell (S)3K$56K
May 13, 2025Larson Stephen P.DirectorBuy (P)10K$225K
Mar 5, 2025Lehner Edward J.President & CEO, DirectorSell (S)10K$248K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
00
Insiders
Form 4 open-market
02-$509K
US House
STOCK Act trades
00$0

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

6 tracked filers in Q1 2025 filingsstill filing
01529Q3 2024Q4 2024Q1 2025
tracked filers holding their reported valueQ1 2025 filings so far: $4K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for RYI

Browse more

Build

Ask your agent what changed in RYI

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/RYI/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for RYI.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + the live filing stream, joined for RYI. Filings are public domain, sourced to SEC EDGAR.